Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.
2.
4.

[Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart].

Ogita H, Node K, Asanuma H, Sanada S, Takashima S, Asakura M, Kitakaze M, Hori M.

J Cardiol. 2002 Jan;39(1):55-6. Japanese.

PMID:
11828800
7.

17beta-Estradiol decreases vulnerability to ventricular arrhythmias by preserving connexin43 protein in infarcted rats.

Chen CC, Lin CC, Lee TM.

Eur J Pharmacol. 2010 Mar 10;629(1-3):73-81. doi: 10.1016/j.ejphar.2009.11.050. Epub 2009 Dec 11.

PMID:
20004189
8.

Lovastatin interferes with the infarct size-limiting effect of ischemic preconditioning and postconditioning in rat hearts.

Kocsis GF, Pipis J, Fekete V, Kovács-Simon A, Odendaal L, Molnár E, Giricz Z, Janáky T, van Rooyen J, Csont T, Ferdinandy P.

Am J Physiol Heart Circ Physiol. 2008 May;294(5):H2406-9. doi: 10.1152/ajpheart.00862.2007. Epub 2008 Mar 21.

9.

Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling.

Zatta AJ, Kin H, Lee G, Wang N, Jiang R, Lust R, Reeves JG, Mykytenko J, Guyton RA, Zhao ZQ, Vinten-Johansen J.

Cardiovasc Res. 2006 May 1;70(2):315-24. Epub 2006 Jan 27.

10.

Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury.

Ozdemir R, Parlakpinar H, Polat A, Colak C, Ermis N, Acet A.

Toxicology. 2006 Feb 15;219(1-3):142-9. Epub 2006 Jan 6.

PMID:
16406210
11.

Downregulation of immunodetectable connexin43 and decreased gap junction size in the pathogenesis of chronic hibernation in the human left ventricle.

Kaprielian RR, Gunning M, Dupont E, Sheppard MN, Rothery SM, Underwood R, Pennell DJ, Fox K, Pepper J, Poole-Wilson PA, Severs NJ.

Circulation. 1998 Feb 24;97(7):651-60.

12.
13.

Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation.

Bulhak A, Roy J, Hedin U, Sjöquist PO, Pernow J.

Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H3158-63. Epub 2007 Feb 23.

14.

Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.

Moolman JA, Hartley S, Van Wyk J, Marais E, Lochner A.

Cardiovasc Drugs Ther. 2006 Feb;20(1):13-25.

PMID:
16552474
15.

Transduction of anti-cell death protein FNK protects isolated rat hearts from myocardial infarction induced by ischemia/reperfusion.

Arakawa M, Yasutake M, Miyamoto M, Takano T, Asoh S, Ohta S.

Life Sci. 2007 May 8;80(22):2076-84. Epub 2007 Apr 1.

PMID:
17467744
16.

Salvia miltiorrhiza treatment during early reperfusion reduced postischemic myocardial injury in the rat.

Nie R, Xia R, Zhong X, Xia Z.

Can J Physiol Pharmacol. 2007 Oct;85(10):1012-9.

PMID:
18066102
17.

Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs.

Hennan JK, Swillo RE, Morgan GA, Keith JC Jr, Schaub RG, Smith RP, Feldman HS, Haugan K, Kantrowitz J, Wang PJ, Abu-Qare A, Butera J, Larsen BD, Crandall DL.

J Pharmacol Exp Ther. 2006 Apr;317(1):236-43. Epub 2005 Dec 12.

18.
19.

Heavy ion radiation up-regulates Cx43 and ameliorates arrhythmogenic substrates in hearts after myocardial infarction.

Amino M, Yoshioka K, Tanabe T, Tanaka E, Mori H, Furusawa Y, Zareba W, Yamazaki M, Nakagawa H, Honjo H, Yasui K, Kamiya K, Kodama I.

Cardiovasc Res. 2006 Dec 1;72(3):412-21. Epub 2006 Sep 20.

20.

Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.

Onogi H, Minatoguchi S, Chen XH, Bao N, Kobayashi H, Misao Y, Yasuda S, Yamaki T, Maruyama R, Uno Y, Arai M, Takemura G, Fujiwara H.

Clin Exp Pharmacol Physiol. 2006 Nov;33(11):1035-41.

PMID:
17042911
Items per page

Supplemental Content

Write to the Help Desk